78 completed, 7 unknown, 6 terminated, 2 not yet recruiting. 31 Phase 4, 25 Phase 3, 15 Phase 1, 13 Phase 2, 10 Not applicable.
Follow Tolterodine Tartrate: new trials by email Literature Review of Tolterodine Tartrate trials Research Report on Tolterodine Tartrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release - Overactive Bladder (OAB) | Phase 3 | Not yet recruiting | NinaMED Pty Ltd | 290 | 2026-09-10 | 2026-08-24 |
| Effect of Antimuscarinic Treatment on Premature Ejaculation Severity in Men With Overactive Bladder: a Prospective Comparison With Mirabegron Tolterodine, Mirabegron (beta3-adrenoceptor agonist) - Overactive Bladder (OAB), Premature (Early) Ejaculation | Completed | Başakşehir Çam & Sakura City Hospital | 40 | 2026-01-15 | 2026-08-13 | |
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
| Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study tolterodine, mirabegron, tolterodine , mirabegron - Female Patients With Overactive Bladder Syndrome | Phase 4 | Unknown | Far Eastern Memorial Hospital | 150 | 2023-09-12 | 2023-09-13 |
| Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery surgery, sacral neuromodulation, botulinum toxin A injection - Spinal Vascular Disorder Nos, Overactive Bladder | Not applicable | Unknown | Xuanwu Hospital, Beijing | 100 | 2023-01-01 | 2020-04-29 |
| TReating Incontinence for Underlying Mental and Physical Health Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence | Phase 4 | Recruiting | University of California, San Francisco | 270 | 2022-10-04 | 2026-03-06 |
| Treatment of Overactive Bladder With Anticholinergic Agents Oxybutynin Cl, propiverine, Tolterodine - Overactive Bladder | Active not recruiting | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | 120 | 2022-09-01 | 2025-07-01 | |
| Oxybutynin for Post-surgical Bladder Pain and Urgency Oxybutynin Transdermal Patch, Oral Oxybutynin - Overactive Bladder Syndrome, Neuropathic Bladder | Phase 3 | Recruiting | University of California, Davis | 100 | 2021-09-01 | 2026-01-29 |
| Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder mirabegron, oxybutynin, tolterodine, solifenacin - Sjogren's Syndrome, Overactive Bladder Syndrome | Phase 4 | Unknown | China Medical University Hospital | 50 | 2021-03-23 | 2021-08-10 |
| Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up. Low dose tadalafil 5 mg, Tolterodine 4 Mg Oral Capsule, Extended Release, Placebo - Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence | Phase 1 | Completed | Kasr El Aini Hospital | 90 | 2020-12-01 | 2022-08-15 |
| Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome Tolterodine Tartrate 4 MG, Continuous positive airway pressure therapy (CPAP) - Overactive Bladder, Obstructive Sleep Apnea | Phase 4 | Completed | Yuzuncu Yil University | 60 | 2020-06-01 | 2022-02-22 |
| Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine - Urinary Incontinence, Urgency Urinary | Phase 4 | Completed | Brigham and Women's Hospital | 20 | 2019-10-30 | 2022-11-15 |
| Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania mirabegron, solifenacin, darifenacin - Overactive Bladder (OAB) | Completed | Astellas Pharma Singapore Pte. Ltd. | 5589 | 2018-07-20 | 2024-10-16 | |
| A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China mirabegron, solifenacin, darifenacin - Overactive Bladder (OAB) | Completed | Astellas Pharma Singapore Pte. Ltd. | 805 | 2018-07-19 | 2020-04-22 | |
| An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). Vibegron, placebos, Tolterodine Tartrate ER - Overactive Bladder | Phase 3 | Completed | Urovant Sciences GmbH | 506 | 2018-06-14 | 2021-03-18 |
| A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) vibegron, Vibegron placebo, Tolterodine Tartrate ER - Overactive Bladder | Phase 3 | Completed | Urovant Sciences GmbH | 1530 | 2018-03-26 | 2021-03-04 |
| Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. Uritos®, Urotol® - Overactive Bladder | Phase 3 | Completed | R-Pharm | 300 | 2016-07-18 | 2019-05-21 |
| Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women EPNS, TT - Urgency-frequency Syndrome | Not applicable | Completed | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 120 | 2016-04-01 | 2017-07-31 |
| Treatment of Incontinence Without Memory Problems Mirabegron, Tolterodine Tartrate - Urge Incontinence, Urinary Incontinence, Urge | Phase 4 | Completed | University of California, San Francisco | 23 | 2016-02-01 | 2019-04-16 |
| the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery transvaginal synthetic mesh, Tolterodine - Pelvic Organ Prolapse | Phase 3 | Unknown | Peking University People's Hospital | 1000 | 2015-08-01 | 2017-05-23 |
Showing 20 of 97. Sign in to see all of them.
Urinary Bladder, Overactive (57) · Urinary Incontinence, Urge (21) · Urinary Incontinence (18) · Lower Urinary Tract Symptoms (4) · Urologic Diseases (3) · Chronic Pain (2) · Nocturia (2) · Female Urogenital Diseases (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Low Back Pain (1) · Male Urogenital Diseases (1) · Neuralgia (1) · Pain (1) · Pelvic Organ Prolapse (1) · Premature Birth (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (10) · Astellas Pharma Inc (8) · Mylan Pharmaceuticals Inc (5) · Insel Gruppe AG, University Hospital Bern (4) · Pfizer (4) · Merck Sharp & Dohme LLC (3) · Astellas Pharma Singapore Pte. Ltd. (2) · Brigham and Women's Hospital (2) · Buddhist Tzu Chi General Hospital (2) · Far Eastern Memorial Hospital (2) · Novartis (2) · Sanofi (2) · University of Alabama at Birmingham (2) · University of California, San Francisco (2) · Urovant Sciences GmbH (2)
United States (41) · Germany (10) · Sweden (10) · Taiwan (10) · South Korea (9) · Switzerland (9) · Canada (8) · Czechia (8) · United Kingdom (8) · Hungary (7) · Poland (7) · Russia (7) · Spain (7) · Italy (6) · Norway (6)
Thomas S Clark, M.D. (3) · Hann-Chorng Kuo, M.D. (2) · James D Carlson, Pharm. D. (2) · Kyu-Sung Lee, Ph.D (2) · Pascal H Vuilleumier, MD (2) · Ulrike Stamer, Professor (2) · Ali Tehranchi, Urologist (1) · Alison Huang, MD, MAS, MPhil (1) · Andreas Siegenthaler, Dr Med (1) · Christopher P. Smith, MD (1)
PMID 37160401, PMID 37811598, PMID 19683731, PMID 35881009, PMID 16215338, PMID 16616268, PMID 17105794, PMID 18584946, PMID 18654615, PMID 18685795, PMID 19070418, PMID 19380256, PMID 19601704, PMID 19625056, PMID 20639023, PMID 21428726, PMID 21905086, PMID 23424164, PMID 23554851, PMID 24246044, PMID 24477421, PMID 24792229, PMID 26376691, PMID 26945271, PMID 28850362, PMID 29777865, PMID 30266334, PMID 30661513, PMID 31222714, PMID 31449805, PMID 31930360, PMID 33122028, PMID 33332699, PMID 33356445, PMID 33469832, PMID 34921665, PMID 34988092, PMID 35685566, PMID 36384907, PMID 37085880, PMID 37148497, PMID 37586052, PMID 37586057, PMID 38430402, PMID 41182445
2017 (2), R01AG075471 (1), R01AT007171 (1)